Kijima Toshiki, Takada-Owada Atsuko, Kokubun Hidetoshi, Uematsu Toshitaka, Takei Kohei, Betsunoh Hironori, Yashi Masahiro, Ishida Kazuyuki, Kamai Takao
Department of Urology, Dokkyo Medical University, Mibu, Japan.
Department of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.
Int J Urol. 2025 Jul;32(7):859-867. doi: 10.1111/iju.70069. Epub 2025 Apr 11.
To evaluate the prognostic impact of intratumoral tertiary lymphoid structures (TLSs) in patients with retroperitoneal sarcoma undergoing primary curative surgery, focusing on their relationship with immune microenvironment components and survival outcomes.
We conducted a retrospective analysis of 29 patients who underwent surgical resection for retroperitoneal sarcoma at Dokkyo Medical University Hospital from 2007 to 2021. TLSs and tumor-infiltrating lymphocytes were assessed in surgical specimens using immunohistochemical staining to identify CD20-positive B, CD3-positive T, and CD8-positive T cells. Disease-specific survival was analyzed via Kaplan-Meier and Cox proportional hazards models, identifying key prognostic factors.
TLSs were identified in 59% of patients, with the highest density in dedifferentiated liposarcoma (DDLPS). TLS-positive patients showed significantly improved survival compared with TLS-negative patients, with the greatest survival observed in those with ≥ 10 TLSs per 100 mm. TLS density was also associated with increased CD8-positive T-cell infiltration, indicating a potentially enhanced immune response. In the subset of DDLPS cases, TLS positivity correlated with prolonged survival, underscoring its prognostic value.
Intratumoral TLSs are associated with improved survival in retroperitoneal sarcoma, especially DDLPS. These findings highlight the need for further studies on the role of TLS maturity and immune microenvironment dynamics in shaping prognosis and treatment outcomes in retroperitoneal sarcoma.
评估原发性根治性手术治疗的腹膜后肉瘤患者瘤内三级淋巴结构(TLSs)的预后影响,重点关注其与免疫微环境成分及生存结果的关系。
我们对2007年至2021年在东海大学医学部附属医院接受腹膜后肉瘤手术切除的29例患者进行了回顾性分析。使用免疫组织化学染色在手术标本中评估TLSs和肿瘤浸润淋巴细胞,以识别CD20阳性B细胞、CD3阳性T细胞和CD8阳性T细胞。通过Kaplan-Meier法和Cox比例风险模型分析疾病特异性生存情况,确定关键预后因素。
59%的患者中发现了TLSs,去分化脂肪肉瘤(DDLPS)中的密度最高。TLS阳性患者的生存情况明显优于TLS阴性患者,每100mm中≥10个TLSs的患者生存情况最佳。TLS密度还与CD8阳性T细胞浸润增加有关,表明免疫反应可能增强。在DDLPS病例亚组中,TLS阳性与生存期延长相关,强调了其预后价值。
瘤内TLSs与腹膜后肉瘤尤其是DDLPS患者的生存改善相关。这些发现凸显了进一步研究TLS成熟度和免疫微环境动态在腹膜后肉瘤预后和治疗结果形成中的作用的必要性。